Hypera

Hypera PEG

PEG Ratio (Price/Earnings-to-Growth) of Hypera (HYPE3.SA) as of Oct 11, 2026.

PEG

-

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Hypera is 2026 - . PEG Ratio (Price/Earnings-to-Growth) of Hypera was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Hypera since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Hypera with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Hypera

All Key Metrics — Hypera